Unusual presentation of primary toxoplasmosis infection in a kidney-transplant patient complicated by an acute left-ventricular failure

NDT Plus

Volumn 1, Issue 6, 2008, Pages 429-432

  Hébraud, Benjamin ^a   Kamar, Nassim ^a   Borde, Jean Sébastien ^a   Bessières, Marie Hélène ^a   Galinier, Michel ^a   Rostaing, Lionel ^a,b  

^a CHU RANGUEIL   (France)

^b INSERM   (France)

Author keywords

Chronic kidney disease; Haemophagocytic syndrome; Heart failure; Myocarditis; Toxoplasmosis

Indexed keywords

AZATHIOPRINE; BISOPROLOL; CLINDAMYCIN; COTRIMOXAZOLE; CREATININE; CYCLOSPORIN; DIGOXIN; FOLINIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PYRIMETHAMINE; RAMIPRIL; SPIRONOLACTONE; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ARTICLE; CASE REPORT; CREATININE BLOOD LEVEL; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HEART LEFT VENTRICLE FAILURE; HEMODIALYSIS; HEMOPHAGOCYTIC SYNDROME; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY HYPOPLASIA; KIDNEY TRANSPLANTATION; MALE; MYOCARDITIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TOXOPLASMA GONDII; TOXOPLASMOSIS; TREATMENT FAILURE; TREATMENT RESPONSE;

EID: 56749186240     PISSN: 17530784     EISSN: 17530792     Source Type: Journal    
DOI: 10.1093/ndtplus/sfn159     Document Type: Article

References (25)

1. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004; 363: 1965-1976
2. Botterel F, Ichai P, Feray C et al. Disseminated toxoplasmosis, resulting from infection of allograft, after orthotopic liver transplantation: usefulness of quantitative PCR. J Clin Microbiol 2002; 40: 1648-1650
3. Wulf MW, van Crevel R, Portier R et al. Toxoplasmosis after renal transplantation: implications of a missed diagnosis. J Clin Microbiol 2005; 43: 3544-3547
4. Assi MA, Rosenblatt JE, Marshall WF. Donor-transmitted toxoplasmosis in liver transplant recipients: a case report and literature review. Transpl Infect Dis 2007; 9: 132-136
5. Kimball AC, Kean BH, Kellner A. The risk of transmitting toxoplasmosis by blood transfusion. Transfusion 1965; 5: 447-451
6. Rostaing L, Baron E, Fillola O et al. Toxoplasmosis in two renal transplant recipients: diagnosis by bone marrow aspiration. Transplant Proc 1995; 27: 1733-1734
7. Segall L, Moal MC, Doucet L et al. Toxoplasmosis-associated hemophagocytic syndrome in renal transplantation. Transpl Int 2006; 19: 78-80
8. Kalderon AE, Kikkawa Y, Bernstein J. Chronic toxoplasmosis associated with severe hemolytic anemia. Case Report and electron microscopic studies. Arch Intern Med 1964; 114: 95-102
9. Blatrix C, Baufine-Ducrocq H, Couzineau P et al. Toxoplasmosis causing immunologic hemolytic anemia. Presse Med 1967; 75: 333-336
10. Bergin M, Menser MA, Procopis PG et al. Central nervous system toxoplasmosis and hemolytic-uremic syndrome. N Engl J Med 1987; 317: 1540-1541
11. Michelson AD, Lammi AT. Haemolytic anaemia associated with acquired toxoplasmosis. Aust Paediatr J 1984; 20: 333-335
12. Soave R. Prophylaxis strategies for solid-organ transplantation. Clin Infect Dis 2001; 33: S26-S31
13. Valar C, Keitel E, Dal Pra RL et al. Parasitic infection in renal transplant recipients. Transplant Proc 2007; 39: 460-462
14. Iqbal J, Nampoory MR, Johnv KV et al. Determination of antibodies to Toxoplasma gondii and CMV in renal transplant recipients. Transplant Proc 2003; 35: 2703-2705
15. Renoult E, Georges E, Biava MF et al. Toxoplasmosis in kidney transplant recipients: report of six cases and review. Clin Infect Dis 1997; 24: 625-634
16. Aubert D, Foudrinier F, Villena I et al. PCR for diagnosis and follow-up of two cases of disseminated toxoplasmosis after kidney grafting. J Clin Microbiol 1996; 34: 1347
17. Wagner FM, Reichenspurner H, Uberfuhr P et al. Toxoplasmosis after heart transplantation: diagnosis by endomyocardial biopsy. J Heart Lung Transplant 1994; 13: 916-918
18. Mariani M, Pagani M, Inserra C et al. Complete atrioventricular block associated with toxoplasma myocarditis. Europace 2006; 8: 221-223
19. Hermanns B, Brunn A, Schwarz ER et al. Fulminant toxoplasmosis in a heart transplant recipient. Pathol Res Pract 2001; 197: 211-215
20. Arora S, Jenum PA, Aukrust P et al. Pre-transplant Toxoplasma gondii seropositivity among heart transplant recipients is associated with an increased risk of all-cause and cardiac mortality. J Am Coll Cardiol 2007; 50: 1967-1972
21. Baden LR, Katz JT, Franck L et al. Successful toxoplasmosis prophylaxis after orthotopic cardiac transplantation with trimethoprim- sulfamethoxazole. Transplantation 2003; 75: 339-343
22. Baran DA, Alwarshetty MM, Alvi S et al. Is toxoplasmosis prophylaxis necessary in cardiac transplantation? Long-term follow-up at two transplant centers. J Heart Lung Transplant 2006; 25: 1380-1382
23. Sarchi E, Genco F, Di Matteo A et al. Surveillance of Toxoplasma gondii infection in recipients of thoracic solid organ transplants. New Microbiol 2007; 30: 299-302
24. Hofman P, Drici MD, Gibelin P et al. Prevalence of toxoplasma myocarditis in patients with the acquired immunodeficiency syndrome. Br Heart J 1993; 70: 376-381
25. Schmidt B, Wieneke H, Fahrenkamp A et al. Encephalitic and myocardial toxoplasmosis masquerading as cytomegalovirus infection in a renal allograft recipient. Nephrol Dial Transplant 1995; 10: 284-286